NewLink Genetics

(NSD:NLNK) Trade

Symbol has changed to a new ticker symbol

(LUMO)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.

Contact Information

Website: www.lumos-pharma.com
Email: ir@lumos-pharma.com
Main Phone: +1 512 215-2630
Address: 4200 Marathon Boulevard
Address 2: Suite 200
State: TX
City / Town: Austin
Country: US
Postal Code: 78756

Issuer Information

Exchange: NSD
CEO: Richard J. Hawkins
Employees: 29
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A